UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000011155
Receipt No. R000013063
Official scientific title of the study Study of the retinal and choroidal thickness after trabeculectomy
Date of disclosure of the study information 2013/07/09
Last modified on 2017/01/03 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study of the retinal and choroidal thickness after trabeculectomy
Title of the study (Brief title) Retinal and choroidal thickness after trabeculectomy
Region
Japan

Condition
Condition Glaucoma
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of the study is to investigate the effect of the trabeculectomy for the retinal and choroidal thickness in primary open angle glaucoma patients.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Intraocular pressure, Retinal thickness, Choroidal thickness
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 trabeculectomy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria Patients with glaucoma resistance to topical glaucoma medications.
Key exclusion criteria 1 Pregnant woman
2 Patients with cataract
Target sample size 50

Research contact person
Name of lead principal investigator Shunsuke Nakakura
Organization Saneikai Tsukazaki Hospital
Division name Department of Ophthalmology
Address Himeji City, Aboshi Waku 68-1
TEL 079-272-8555
Email shunsukenakakura@yahoo.co.jp

Public contact
Name of contact person Shunsuke Nakakura
Organization Saneikai Tsukazaki Hospital
Division name Department of Ophthalmology
Address Saneikai Tsukazaki Hospital
TEL 079-272-8555
Homepage URL
Email shunsukenakakura@yahoo.co.jp

Sponsor
Institute Saneikai Tsukazaki Hospital
Institute
Department

Funding Source
Organization Saneikai Tsukazaki Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 07 Month 09 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 07 Month 09 Day
Anticipated trial start date
2013 Year 07 Month 09 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results In sufficient of Patients.
Other related information None

Management information
Registered date
2013 Year 07 Month 09 Day
Last modified on
2017 Year 01 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013063